勃起脊柱平面阻塞可以减少术后恶心和吐: 44项随机试验的系统性审查和元分析
Chong Zhao1, Minmin Zhu2, Jinjin Jian3
1Department of Anesthesiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Frontiers in medicine
|February 2, 2026
概括
勃起器脊柱平面块 (ESPB) 显著减少术后恶心和吐 (PONV). 这一元分析证实了ESPB的说法.
科学领域:
- 麻醉学 麻醉学
- 手术并发症 手术并发症
- 疼痛管理 疼痛管理
背景情况:
- 手术后恶心和吐 (PONV) 是一种常见且具有挑战性的并发症.
- 勃起器脊柱平面块 (ESPB) 以其止痛特性而闻名.
- 证据证明ESPB在减少PONV方面的有效性有限.
研究的目的:
- 评估ESPB对PONV发病率的影响.
- 评估ESPB是否能为PONV提供除了减轻疼痛之外的好处.
- 综合关于ESPB和PONV的现有证据.
主要方法:
- 一项涉及2830名患者的44项试验的综合元分析.
- 在PubMed,Embase和Cochrane中央注册表中进行了搜索.
- 使用审查管理器软件分析数据.
主要成果:
- ESPB显著减少了恶心 (RD = -0.16) 和吐 (RD = -0.12).
- 降低了阿片类药物需求 (吗啡,芬太尼,特拉马多尔) 和疼痛评分 (VAS).
- 降低了头的发生率,增加了的可能性.
结论:
- ESPB有效地减少了PONV的发生率.
- 阻断增强术后恢复的质量.
- 试验的顺序分析证实了这些发现的样本大小足够.
相关概念视频
Random and Systematic Errors
14.9K
Scientists always try their best to record measurements with the utmost accuracy and precision. However, sometimes errors do occur. These errors can be random or systematic. Random errors are observed due to the inconsistency or fluctuation in the measurement process, or variations in the quantity itself that is being measured. Such errors fluctuate from being greater than or less than the true value in repeated measurements. Consider a scientist measuring the length of an earthworm using a...
14.9K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
783
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
783
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
668
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
668
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
884
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
884
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
622
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
622
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
248
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
248


